NCT02255942

Brief Summary

Investigation of Iron Bioavailability from extruded rice grains fortified with Ferric Pyrophosphate alone or in combination with different Zinc Compounds; Ferrous Sulfate serves as a Reference.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 19, 2014

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 3, 2014

Completed
6 months until next milestone

Study Start

First participant enrolled

April 1, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
Last Updated

April 14, 2016

Status Verified

September 1, 2015

Enrollment Period

2 months

First QC Date

September 19, 2014

Last Update Submit

April 13, 2016

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change from baseline in the isotopic ratio of iron in blood at week 2

    The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.

    baseline, 2 weeks

  • Change from week 2 in the isotopic ratio of iron in blood at week 4

    The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.

    2 weeks, 4 weeks

  • Change from week 4 in the isotopic ratio of iron in blood at week 6

    The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.

    4 weeks, 6 weeks

Secondary Outcomes (3)

  • Haemoglobin

    baseline, 16th, 30th and 44th day

  • Plasma Ferritin

    baseline, 16th, 30th and 44th day

  • C reactive protein

    baseline, 16th, 30th and 44th day

Study Arms (1)

Iron fortified rice

EXPERIMENTAL

Administration of iron fortified rice to all subjects; subjects will act as their own controls and each subject will receive all foreseen treatments/interventions.

Other: Ferric Pyrophosphate and Zinc OxideOther: Ferrous sulfateOther: Ferric Pyrophosphate and Zinc SulfateOther: Ferric Pyrophosphate

Interventions

Rice fortified with Ferric Pyrophosphate and Zinc Oxide (ZnO)

Iron fortified rice

Rice fortified with Ferrous Sulfate (ZnSO4)

Iron fortified rice

Rice fortified with Ferric Pyrophosphate and Zinc Sulfate

Iron fortified rice

Rice fortified with Ferric Pyrophosphate

Iron fortified rice

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Female
  • Serum Ferritin Level \< 15 µg/L
  • Body weight \<65 kg
  • Signed informed consent 4. Body Mass Index in the range of 18.5 to 25

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ETH Zürich, Laboratory of Human Nutrition

Zurich, Canton of Zurich, 8092, Switzerland

Location

Related Publications (1)

  • Hackl L, Zimmermann MB, Zeder C, Parker M, Johns PW, Hurrell RF, Moretti D. Iron Bioavailability from Ferric Pyrophosphate in Extruded Rice Cofortified with Zinc Sulfate Is Greater than When Cofortified with Zinc Oxide in a Human Stable Isotope Study. J Nutr. 2017 Mar;147(3):377-383. doi: 10.3945/jn.116.241778. Epub 2017 Feb 1.

MeSH Terms

Conditions

Iron Deficiencies

Interventions

ferric pyrophosphateZinc Oxideferrous sulfateZinc Sulfate

Condition Hierarchy (Ancestors)

Iron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

OxidesOxygen CompoundsInorganic ChemicalsZinc CompoundsSulfatesSulfuric AcidsSulfur AcidsSulfur Compounds

Study Officials

  • Michael Zimmermann, Prof.Dr., MD

    ETH Zürich

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.Dr.

Study Record Dates

First Submitted

September 19, 2014

First Posted

October 3, 2014

Study Start

April 1, 2015

Primary Completion

June 1, 2015

Study Completion

July 1, 2015

Last Updated

April 14, 2016

Record last verified: 2015-09

Locations